Kevin Michael Coveney - 13 Mar 2023 Form 4 Insider Report for Enveric Biosciences, Inc. (ENVB)

Role
Chief Financial Officer
Signature
/s/ Kevin M. Coveney
Issuer symbol
ENVB
Transactions as of
13 Mar 2023
Net transactions value
$0
Form type
4
Filing time
14 Mar 2023, 19:24:03 UTC
Next filing
26 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENVB Common Stock Award $0 +26,500 $0.000000 26,500 13 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units (the "RSUs") granted to the reporting person. For each vested RSU, the reporting person will be entitled to receive one share of common stock.
F2 The RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on March 13, 2024.